SV

Street Verdict

Analyst Scorecard

A record of what Hemant Kanawala said publicly, with the source. Not advice.

Pending — not yet graded
“Bearish on the pharma sector in the near term due to uncertainty surrounding potential US tariffs. While tariffs haven't been announced, the US President's reiteration of upcoming tariffs has already led to a correction in pharma stocks.”
Nifty PharmaBearishCalled 15 May 2025
Verdict:PENDING

This call has no verdict yet — it is graded HIT or MISS against real price data once a close decides it. Save it above to find it again from your profile.

Read the original articleSee Hemant Kanawala’s full track record